Hematology Comprehensive Study by Type (Hematology analyzers, Flow cytometers, Cell counters, Slide strainers, Coagulation analyzers, Hematology testing, Centrifuges, Hemoglobinometers DD, Others), Application (Infectious diseases, Blood screening, Diabetes, HIV, Cancer, Cardiovascular diseases, Others), End user (Hospital laboratories, Commercial service providers, Government reference laboratories, Research & academic institutes) Players and Region - Global Market Outlook to 2025

Hematology Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 5%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Hematology Market Overview:
The high incidence of blood and blood-related disorders leading to the usage of hematology and emergence of high throughput hematology analyzer is driving the Global Hematology market. Approximately one person is diagnosed with blood cancer every 3 minutes in the United States. Hematology is a branch of medicine which involves the study of blood in health and diseases. The disorders include Anemia, Malaria, Thalassemia, Myelodysplastic syndrome, etc. Along with this, the increasing incidence of kidney diseases is also expected to induce huge growth in the hematology market. Hematology analyzers are large automated integrated systems that combine all forms of sample processing, analysis, and presentation of results. The analyzer also helps in pre and post-analytical sample handling and management of reagent supply with limited user interference. The analyzer also helps laboratories generate results in faster turnaround time, thereby improving the efficiency and labor utilization. According to the National Hemophilia Foundation According to AMA, the Global Hematology market is expected to see growth rate of 5.0%

Market Drivers
  • Increasing incidence of blood disorders and the rising rate of blood donation
  • Technological advancement in hematology analyzer and reagents
  • Integration of techniques like Flow Cytometry with hematology analyzer.

Market Trend
  • Growing incidence of blood disorders among the population.
  • Involvement of Automation in hematology instruments.

Restraints
  • High cost of equipment and reagents
  • Poor health insurance coverage.

Opportunities
  • Availability of a large number of diagnostic centers and adoption of highly adopted hematology analyzers by the laboratories.

Challenges
  • High cost of the instrument (Hematology analyzer) which is available in a portable and advanced form is making it difficult for small vendors to invest in the market.


Competitive Landscape:
The market is fragmented with many global key players who are adopting the strategy of merger and acquisition to sustain in the global hematology market. Established vendors of laboratory equipment are supplying new models of hematology analyzers at competitive prices, helping laboratories to enhance their capabilities, productivity, and workflow. They are also offering recertified instruments and reagent rental plans which is beneficial for laboratories with budget constraints.
Some of the key players profiled in the report are Sysmex (Japan), Danaher (United States), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (United States), Boule Diagnostics (Europe), HORIBA (Japan), Bio-Rad Laboratories (United States), Bio Systems (Europe), Diatron (Europe) and Drew Scientific (United States). Additionally, following companies can also be profiled that are part of our coverage like EKF Diagnostics (U.K.), Mindray (China), Ortho Clinical Diagnostics (United States) and Roche (Europe). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Hematology market by 2025. Considering Market by End user, the sub-segment i.e. Hospital laboratories will boost the Hematology market.

Market Highlights:
On September 2018, Sysmex launches new product for China market i.e. Hematology Analyzer XS-Series which is designed for high performance, compactness and has the ability to measure minute quantities of blood.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Hematology market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Hematology market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Healthcare providers, Government and regulatory bodies, Hematology Instrument manufacturers, Distributors and Suppliers, Pharmaceutical Companies and Clinics.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Hematology analyzers
  • Flow cytometers
  • Cell counters
  • Slide strainers
  • Coagulation analyzers
  • Hematology testing
  • Centrifuges
  • Hemoglobinometers DD
  • Others
By Application
  • Infectious diseases
  • Blood screening
  • Diabetes
  • HIV
  • Cancer
  • Cardiovascular diseases
  • Others
By End user
  • Hospital laboratories
  • Commercial service providers
  • Government reference laboratories
  • Research & academic institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing incidence of blood disorders and the rising rate of blood donation
      • 3.2.2. Technological advancement in hematology analyzer and reagents
      • 3.2.3. Integration of techniques like Flow Cytometry with hematology analyzer.
    • 3.3. Market Challenges
      • 3.3.1. High cost of the instrument (Hematology analyzer) which is available in a portable and advanced form is making it difficult for small vendors to invest in the market.
    • 3.4. Market Trends
      • 3.4.1. Growing incidence of blood disorders among the population.
      • 3.4.2. Involvement of Automation in hematology instruments.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Hematology, by Type, Application, End user and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Hematology (Value)
      • 5.2.1. Global Hematology by: Type (Value)
        • 5.2.1.1. Hematology analyzers
        • 5.2.1.2. Flow cytometers
        • 5.2.1.3. Cell counters
        • 5.2.1.4. Slide strainers
        • 5.2.1.5. Coagulation analyzers
        • 5.2.1.6. Hematology testing
        • 5.2.1.7. Centrifuges
        • 5.2.1.8. Hemoglobinometers DD
        • 5.2.1.9. Others
      • 5.2.2. Global Hematology by: Application (Value)
        • 5.2.2.1. Infectious diseases
        • 5.2.2.2. Blood screening
        • 5.2.2.3. Diabetes
        • 5.2.2.4. HIV
        • 5.2.2.5. Cancer
        • 5.2.2.6. Cardiovascular diseases
        • 5.2.2.7. Others
      • 5.2.3. Global Hematology by: End user (Value)
        • 5.2.3.1. Hospital laboratories
        • 5.2.3.2. Commercial service providers
        • 5.2.3.3. Government reference laboratories
        • 5.2.3.4. Research & academic institutes
      • 5.2.4. Global Hematology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Hematology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sysmex (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Danaher (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Nihon Kohden (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Siemens (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abbott Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Boule Diagnostics (Europe)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. HORIBA (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Rad Laboratories (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bio Systems (Europe)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Diatron (Europe)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Drew Scientific (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Hematology Sale, by Type, Application, End user and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Hematology (Value)
      • 7.2.1. Global Hematology by: Type (Value)
        • 7.2.1.1. Hematology analyzers
        • 7.2.1.2. Flow cytometers
        • 7.2.1.3. Cell counters
        • 7.2.1.4. Slide strainers
        • 7.2.1.5. Coagulation analyzers
        • 7.2.1.6. Hematology testing
        • 7.2.1.7. Centrifuges
        • 7.2.1.8. Hemoglobinometers DD
        • 7.2.1.9. Others
      • 7.2.2. Global Hematology by: Application (Value)
        • 7.2.2.1. Infectious diseases
        • 7.2.2.2. Blood screening
        • 7.2.2.3. Diabetes
        • 7.2.2.4. HIV
        • 7.2.2.5. Cancer
        • 7.2.2.6. Cardiovascular diseases
        • 7.2.2.7. Others
      • 7.2.3. Global Hematology by: End user (Value)
        • 7.2.3.1. Hospital laboratories
        • 7.2.3.2. Commercial service providers
        • 7.2.3.3. Government reference laboratories
        • 7.2.3.4. Research & academic institutes
      • 7.2.4. Global Hematology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Hematology: by Type(USD Million)
  • Table 2. Hematology Hematology analyzers , by Region USD Million (2013-2018)
  • Table 3. Hematology Flow cytometers , by Region USD Million (2013-2018)
  • Table 4. Hematology Cell counters , by Region USD Million (2013-2018)
  • Table 5. Hematology Slide strainers , by Region USD Million (2013-2018)
  • Table 6. Hematology Coagulation analyzers , by Region USD Million (2013-2018)
  • Table 7. Hematology Hematology testing , by Region USD Million (2013-2018)
  • Table 8. Hematology Centrifuges , by Region USD Million (2013-2018)
  • Table 9. Hematology Hemoglobinometers DD , by Region USD Million (2013-2018)
  • Table 10. Hematology Others , by Region USD Million (2013-2018)
  • Table 11. Hematology: by Application(USD Million)
  • Table 12. Hematology Infectious diseases , by Region USD Million (2013-2018)
  • Table 13. Hematology Blood screening , by Region USD Million (2013-2018)
  • Table 14. Hematology Diabetes , by Region USD Million (2013-2018)
  • Table 15. Hematology HIV , by Region USD Million (2013-2018)
  • Table 16. Hematology Cancer , by Region USD Million (2013-2018)
  • Table 17. Hematology Cardiovascular diseases , by Region USD Million (2013-2018)
  • Table 18. Hematology Others , by Region USD Million (2013-2018)
  • Table 19. Hematology: by End user(USD Million)
  • Table 20. Hematology Hospital laboratories , by Region USD Million (2013-2018)
  • Table 21. Hematology Commercial service providers , by Region USD Million (2013-2018)
  • Table 22. Hematology Government reference laboratories , by Region USD Million (2013-2018)
  • Table 23. Hematology Research & academic institutes , by Region USD Million (2013-2018)
  • Table 24. South America Hematology, by Country USD Million (2013-2018)
  • Table 25. South America Hematology, by Type USD Million (2013-2018)
  • Table 26. South America Hematology, by Application USD Million (2013-2018)
  • Table 27. South America Hematology, by End user USD Million (2013-2018)
  • Table 28. Brazil Hematology, by Type USD Million (2013-2018)
  • Table 29. Brazil Hematology, by Application USD Million (2013-2018)
  • Table 30. Brazil Hematology, by End user USD Million (2013-2018)
  • Table 31. Argentina Hematology, by Type USD Million (2013-2018)
  • Table 32. Argentina Hematology, by Application USD Million (2013-2018)
  • Table 33. Argentina Hematology, by End user USD Million (2013-2018)
  • Table 34. Rest of South America Hematology, by Type USD Million (2013-2018)
  • Table 35. Rest of South America Hematology, by Application USD Million (2013-2018)
  • Table 36. Rest of South America Hematology, by End user USD Million (2013-2018)
  • Table 37. Asia Pacific Hematology, by Country USD Million (2013-2018)
  • Table 38. Asia Pacific Hematology, by Type USD Million (2013-2018)
  • Table 39. Asia Pacific Hematology, by Application USD Million (2013-2018)
  • Table 40. Asia Pacific Hematology, by End user USD Million (2013-2018)
  • Table 41. China Hematology, by Type USD Million (2013-2018)
  • Table 42. China Hematology, by Application USD Million (2013-2018)
  • Table 43. China Hematology, by End user USD Million (2013-2018)
  • Table 44. Japan Hematology, by Type USD Million (2013-2018)
  • Table 45. Japan Hematology, by Application USD Million (2013-2018)
  • Table 46. Japan Hematology, by End user USD Million (2013-2018)
  • Table 47. India Hematology, by Type USD Million (2013-2018)
  • Table 48. India Hematology, by Application USD Million (2013-2018)
  • Table 49. India Hematology, by End user USD Million (2013-2018)
  • Table 50. South Korea Hematology, by Type USD Million (2013-2018)
  • Table 51. South Korea Hematology, by Application USD Million (2013-2018)
  • Table 52. South Korea Hematology, by End user USD Million (2013-2018)
  • Table 53. Taiwan Hematology, by Type USD Million (2013-2018)
  • Table 54. Taiwan Hematology, by Application USD Million (2013-2018)
  • Table 55. Taiwan Hematology, by End user USD Million (2013-2018)
  • Table 56. Australia Hematology, by Type USD Million (2013-2018)
  • Table 57. Australia Hematology, by Application USD Million (2013-2018)
  • Table 58. Australia Hematology, by End user USD Million (2013-2018)
  • Table 59. Rest of Asia-Pacific Hematology, by Type USD Million (2013-2018)
  • Table 60. Rest of Asia-Pacific Hematology, by Application USD Million (2013-2018)
  • Table 61. Rest of Asia-Pacific Hematology, by End user USD Million (2013-2018)
  • Table 62. Europe Hematology, by Country USD Million (2013-2018)
  • Table 63. Europe Hematology, by Type USD Million (2013-2018)
  • Table 64. Europe Hematology, by Application USD Million (2013-2018)
  • Table 65. Europe Hematology, by End user USD Million (2013-2018)
  • Table 66. Germany Hematology, by Type USD Million (2013-2018)
  • Table 67. Germany Hematology, by Application USD Million (2013-2018)
  • Table 68. Germany Hematology, by End user USD Million (2013-2018)
  • Table 69. France Hematology, by Type USD Million (2013-2018)
  • Table 70. France Hematology, by Application USD Million (2013-2018)
  • Table 71. France Hematology, by End user USD Million (2013-2018)
  • Table 72. Italy Hematology, by Type USD Million (2013-2018)
  • Table 73. Italy Hematology, by Application USD Million (2013-2018)
  • Table 74. Italy Hematology, by End user USD Million (2013-2018)
  • Table 75. United Kingdom Hematology, by Type USD Million (2013-2018)
  • Table 76. United Kingdom Hematology, by Application USD Million (2013-2018)
  • Table 77. United Kingdom Hematology, by End user USD Million (2013-2018)
  • Table 78. Netherlands Hematology, by Type USD Million (2013-2018)
  • Table 79. Netherlands Hematology, by Application USD Million (2013-2018)
  • Table 80. Netherlands Hematology, by End user USD Million (2013-2018)
  • Table 81. Rest of Europe Hematology, by Type USD Million (2013-2018)
  • Table 82. Rest of Europe Hematology, by Application USD Million (2013-2018)
  • Table 83. Rest of Europe Hematology, by End user USD Million (2013-2018)
  • Table 84. MEA Hematology, by Country USD Million (2013-2018)
  • Table 85. MEA Hematology, by Type USD Million (2013-2018)
  • Table 86. MEA Hematology, by Application USD Million (2013-2018)
  • Table 87. MEA Hematology, by End user USD Million (2013-2018)
  • Table 88. Middle East Hematology, by Type USD Million (2013-2018)
  • Table 89. Middle East Hematology, by Application USD Million (2013-2018)
  • Table 90. Middle East Hematology, by End user USD Million (2013-2018)
  • Table 91. Africa Hematology, by Type USD Million (2013-2018)
  • Table 92. Africa Hematology, by Application USD Million (2013-2018)
  • Table 93. Africa Hematology, by End user USD Million (2013-2018)
  • Table 94. North America Hematology, by Country USD Million (2013-2018)
  • Table 95. North America Hematology, by Type USD Million (2013-2018)
  • Table 96. North America Hematology, by Application USD Million (2013-2018)
  • Table 97. North America Hematology, by End user USD Million (2013-2018)
  • Table 98. United States Hematology, by Type USD Million (2013-2018)
  • Table 99. United States Hematology, by Application USD Million (2013-2018)
  • Table 100. United States Hematology, by End user USD Million (2013-2018)
  • Table 101. Canada Hematology, by Type USD Million (2013-2018)
  • Table 102. Canada Hematology, by Application USD Million (2013-2018)
  • Table 103. Canada Hematology, by End user USD Million (2013-2018)
  • Table 104. Mexico Hematology, by Type USD Million (2013-2018)
  • Table 105. Mexico Hematology, by Application USD Million (2013-2018)
  • Table 106. Mexico Hematology, by End user USD Million (2013-2018)
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Company Basic Information, Sales Area and Its Competitors
  • Table 118. Hematology: by Type(USD Million)
  • Table 119. Hematology Hematology analyzers , by Region USD Million (2020-2025)
  • Table 120. Hematology Flow cytometers , by Region USD Million (2020-2025)
  • Table 121. Hematology Cell counters , by Region USD Million (2020-2025)
  • Table 122. Hematology Slide strainers , by Region USD Million (2020-2025)
  • Table 123. Hematology Coagulation analyzers , by Region USD Million (2020-2025)
  • Table 124. Hematology Hematology testing , by Region USD Million (2020-2025)
  • Table 125. Hematology Centrifuges , by Region USD Million (2020-2025)
  • Table 126. Hematology Hemoglobinometers DD , by Region USD Million (2020-2025)
  • Table 127. Hematology Others , by Region USD Million (2020-2025)
  • Table 128. Hematology: by Application(USD Million)
  • Table 129. Hematology Infectious diseases , by Region USD Million (2020-2025)
  • Table 130. Hematology Blood screening , by Region USD Million (2020-2025)
  • Table 131. Hematology Diabetes , by Region USD Million (2020-2025)
  • Table 132. Hematology HIV , by Region USD Million (2020-2025)
  • Table 133. Hematology Cancer , by Region USD Million (2020-2025)
  • Table 134. Hematology Cardiovascular diseases , by Region USD Million (2020-2025)
  • Table 135. Hematology Others , by Region USD Million (2020-2025)
  • Table 136. Hematology: by End user(USD Million)
  • Table 137. Hematology Hospital laboratories , by Region USD Million (2020-2025)
  • Table 138. Hematology Commercial service providers , by Region USD Million (2020-2025)
  • Table 139. Hematology Government reference laboratories , by Region USD Million (2020-2025)
  • Table 140. Hematology Research & academic institutes , by Region USD Million (2020-2025)
  • Table 141. South America Hematology, by Country USD Million (2020-2025)
  • Table 142. South America Hematology, by Type USD Million (2020-2025)
  • Table 143. South America Hematology, by Application USD Million (2020-2025)
  • Table 144. South America Hematology, by End user USD Million (2020-2025)
  • Table 145. Brazil Hematology, by Type USD Million (2020-2025)
  • Table 146. Brazil Hematology, by Application USD Million (2020-2025)
  • Table 147. Brazil Hematology, by End user USD Million (2020-2025)
  • Table 148. Argentina Hematology, by Type USD Million (2020-2025)
  • Table 149. Argentina Hematology, by Application USD Million (2020-2025)
  • Table 150. Argentina Hematology, by End user USD Million (2020-2025)
  • Table 151. Rest of South America Hematology, by Type USD Million (2020-2025)
  • Table 152. Rest of South America Hematology, by Application USD Million (2020-2025)
  • Table 153. Rest of South America Hematology, by End user USD Million (2020-2025)
  • Table 154. Asia Pacific Hematology, by Country USD Million (2020-2025)
  • Table 155. Asia Pacific Hematology, by Type USD Million (2020-2025)
  • Table 156. Asia Pacific Hematology, by Application USD Million (2020-2025)
  • Table 157. Asia Pacific Hematology, by End user USD Million (2020-2025)
  • Table 158. China Hematology, by Type USD Million (2020-2025)
  • Table 159. China Hematology, by Application USD Million (2020-2025)
  • Table 160. China Hematology, by End user USD Million (2020-2025)
  • Table 161. Japan Hematology, by Type USD Million (2020-2025)
  • Table 162. Japan Hematology, by Application USD Million (2020-2025)
  • Table 163. Japan Hematology, by End user USD Million (2020-2025)
  • Table 164. India Hematology, by Type USD Million (2020-2025)
  • Table 165. India Hematology, by Application USD Million (2020-2025)
  • Table 166. India Hematology, by End user USD Million (2020-2025)
  • Table 167. South Korea Hematology, by Type USD Million (2020-2025)
  • Table 168. South Korea Hematology, by Application USD Million (2020-2025)
  • Table 169. South Korea Hematology, by End user USD Million (2020-2025)
  • Table 170. Taiwan Hematology, by Type USD Million (2020-2025)
  • Table 171. Taiwan Hematology, by Application USD Million (2020-2025)
  • Table 172. Taiwan Hematology, by End user USD Million (2020-2025)
  • Table 173. Australia Hematology, by Type USD Million (2020-2025)
  • Table 174. Australia Hematology, by Application USD Million (2020-2025)
  • Table 175. Australia Hematology, by End user USD Million (2020-2025)
  • Table 176. Rest of Asia-Pacific Hematology, by Type USD Million (2020-2025)
  • Table 177. Rest of Asia-Pacific Hematology, by Application USD Million (2020-2025)
  • Table 178. Rest of Asia-Pacific Hematology, by End user USD Million (2020-2025)
  • Table 179. Europe Hematology, by Country USD Million (2020-2025)
  • Table 180. Europe Hematology, by Type USD Million (2020-2025)
  • Table 181. Europe Hematology, by Application USD Million (2020-2025)
  • Table 182. Europe Hematology, by End user USD Million (2020-2025)
  • Table 183. Germany Hematology, by Type USD Million (2020-2025)
  • Table 184. Germany Hematology, by Application USD Million (2020-2025)
  • Table 185. Germany Hematology, by End user USD Million (2020-2025)
  • Table 186. France Hematology, by Type USD Million (2020-2025)
  • Table 187. France Hematology, by Application USD Million (2020-2025)
  • Table 188. France Hematology, by End user USD Million (2020-2025)
  • Table 189. Italy Hematology, by Type USD Million (2020-2025)
  • Table 190. Italy Hematology, by Application USD Million (2020-2025)
  • Table 191. Italy Hematology, by End user USD Million (2020-2025)
  • Table 192. United Kingdom Hematology, by Type USD Million (2020-2025)
  • Table 193. United Kingdom Hematology, by Application USD Million (2020-2025)
  • Table 194. United Kingdom Hematology, by End user USD Million (2020-2025)
  • Table 195. Netherlands Hematology, by Type USD Million (2020-2025)
  • Table 196. Netherlands Hematology, by Application USD Million (2020-2025)
  • Table 197. Netherlands Hematology, by End user USD Million (2020-2025)
  • Table 198. Rest of Europe Hematology, by Type USD Million (2020-2025)
  • Table 199. Rest of Europe Hematology, by Application USD Million (2020-2025)
  • Table 200. Rest of Europe Hematology, by End user USD Million (2020-2025)
  • Table 201. MEA Hematology, by Country USD Million (2020-2025)
  • Table 202. MEA Hematology, by Type USD Million (2020-2025)
  • Table 203. MEA Hematology, by Application USD Million (2020-2025)
  • Table 204. MEA Hematology, by End user USD Million (2020-2025)
  • Table 205. Middle East Hematology, by Type USD Million (2020-2025)
  • Table 206. Middle East Hematology, by Application USD Million (2020-2025)
  • Table 207. Middle East Hematology, by End user USD Million (2020-2025)
  • Table 208. Africa Hematology, by Type USD Million (2020-2025)
  • Table 209. Africa Hematology, by Application USD Million (2020-2025)
  • Table 210. Africa Hematology, by End user USD Million (2020-2025)
  • Table 211. North America Hematology, by Country USD Million (2020-2025)
  • Table 212. North America Hematology, by Type USD Million (2020-2025)
  • Table 213. North America Hematology, by Application USD Million (2020-2025)
  • Table 214. North America Hematology, by End user USD Million (2020-2025)
  • Table 215. United States Hematology, by Type USD Million (2020-2025)
  • Table 216. United States Hematology, by Application USD Million (2020-2025)
  • Table 217. United States Hematology, by End user USD Million (2020-2025)
  • Table 218. Canada Hematology, by Type USD Million (2020-2025)
  • Table 219. Canada Hematology, by Application USD Million (2020-2025)
  • Table 220. Canada Hematology, by End user USD Million (2020-2025)
  • Table 221. Mexico Hematology, by Type USD Million (2020-2025)
  • Table 222. Mexico Hematology, by Application USD Million (2020-2025)
  • Table 223. Mexico Hematology, by End user USD Million (2020-2025)
  • Table 224. Research Programs/Design for This Report
  • Table 225. Key Data Information from Secondary Sources
  • Table 226. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Hematology: by Type USD Million (2013-2018)
  • Figure 5. Global Hematology: by Application USD Million (2013-2018)
  • Figure 6. Global Hematology: by End user USD Million (2013-2018)
  • Figure 7. South America Hematology Share (%), by Country
  • Figure 8. Asia Pacific Hematology Share (%), by Country
  • Figure 9. Europe Hematology Share (%), by Country
  • Figure 10. MEA Hematology Share (%), by Country
  • Figure 11. North America Hematology Share (%), by Country
  • Figure 12. Global Hematology share by Players 2018 (%)
  • Figure 13. Global Hematology share by Players (Top 3) 2018(%)
  • Figure 14. Global Hematology share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Sysmex (Japan) Revenue, Net Income and Gross profit
  • Figure 17. Sysmex (Japan) Revenue: by Geography 2018
  • Figure 18. Danaher (United States) Revenue, Net Income and Gross profit
  • Figure 19. Danaher (United States) Revenue: by Geography 2018
  • Figure 20. Nihon Kohden (Japan) Revenue, Net Income and Gross profit
  • Figure 21. Nihon Kohden (Japan) Revenue: by Geography 2018
  • Figure 22. Siemens (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Siemens (Germany) Revenue: by Geography 2018
  • Figure 24. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 25. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 26. Boule Diagnostics (Europe) Revenue, Net Income and Gross profit
  • Figure 27. Boule Diagnostics (Europe) Revenue: by Geography 2018
  • Figure 28. HORIBA (Japan) Revenue, Net Income and Gross profit
  • Figure 29. HORIBA (Japan) Revenue: by Geography 2018
  • Figure 30. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 31. Bio-Rad Laboratories (United States) Revenue: by Geography 2018
  • Figure 32. Bio Systems (Europe) Revenue, Net Income and Gross profit
  • Figure 33. Bio Systems (Europe) Revenue: by Geography 2018
  • Figure 34. Diatron (Europe) Revenue, Net Income and Gross profit
  • Figure 35. Diatron (Europe) Revenue: by Geography 2018
  • Figure 36. Drew Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 37. Drew Scientific (United States) Revenue: by Geography 2018
  • Figure 38. Global Hematology: by Type USD Million (2013-2018)
  • Figure 39. Global Hematology: by Application USD Million (2013-2018)
  • Figure 40. Global Hematology: by End user USD Million (2013-2018)
  • Figure 41. South America Hematology Share (%), by Country
  • Figure 42. Asia Pacific Hematology Share (%), by Country
  • Figure 43. Europe Hematology Share (%), by Country
  • Figure 44. MEA Hematology Share (%), by Country
  • Figure 45. North America Hematology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sysmex (Japan)
  • Danaher (United States)
  • Nihon Kohden (Japan)
  • Siemens (Germany)
  • Abbott Laboratories (United States)
  • Boule Diagnostics (Europe)
  • HORIBA (Japan)
  • Bio-Rad Laboratories (United States)
  • Bio Systems (Europe)
  • Diatron (Europe)
  • Drew Scientific (United States)
Additional players considered in the study are as follows:
EKF Diagnostics (U.K.) , Mindray (China) , Ortho Clinical Diagnostics (United States) , Roche (Europe)
Select User Access Type

Key Highlights of Report


Feb 2019 231 Pages 50 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Hematology Market Report?